Related Experiment Videos
Early treatment of familial hypophosphataemic rickets
Archives of Disease in Childhood
|December 1, 1983
Insights
This study details a young girl with familial hypophosphataemic rickets treated early with vitamin D and phosphate. Early intervention prevented bone lesions, demonstrating effective management of this genetic disorder.
Area of Science:
- Pediatric Endocrinology
- Genetics
- Metabolic Bone Disease
Background:
- Familial hypophosphataemic rickets is a genetic disorder affecting phosphate metabolism.
- Early diagnosis and treatment are crucial for managing rickets.
- The condition requires long-term therapeutic strategies.
Observation:
- A 2.5-year-old female diagnosed with familial hypophosphataemic rickets at 2 months of age.
- The patient received continuous oral treatment with 1 alpha,25-dihydroxycholecalciferol and phosphate.
- Treatment commenced shortly after diagnosis.
Findings:
- The patient has remained free of osseous lesions to date.
- Sustained therapeutic intervention appears to prevent skeletal deformities.
- This suggests the efficacy of the combined treatment regimen.
Implications:
- Early and consistent treatment can successfully prevent the development of bone lesions in familial hypophosphataemic rickets.
- This case highlights the importance of proactive management in pediatric metabolic bone diseases.
- Further research into long-term outcomes and optimal dosing is warranted.
Abstract:
A 2 1/2 year old girl in whom familial hypophosphataemic rickets was diagnosed at age 2 months, has been treated since then with oral 1 alpha,25-dihydroxycholecalciferol and phosphate. She has not, so far, developed osseous lesions.